Skip to main content
Menu
US

Specialized and Customized Assays

Tailored precision for your research needs

At Revvity Omics, we pride ourselves on our ability to develop a wide range of specialized assays that cater to the unique needs of the scientific community. Our expertise spans from biomarker discovery to clinical diagnostic next-generation sequencing (NGS) assays, ensuring that we can support your research at every stage.

Recognizing that standard solutions may not always meet your specific research needs; we offer customized assay development services. Our team of experts collaborates with you to design and develop assays tailored to your unique requirements, ensuring precision and reliability in your research outcomes.

Partner with Revvity Omics to explore our research solutions and unlock the full potential of your scientific endeavors. Our specialized and customized assays are designed to meet the high standards of quality and performance, empowering you to achieve your research goals with confidence.

This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.

Specialized and Customized Assays

EURORealTime APOE testing

Apolipoprotein E (ApoE) is a component of various lipoproteins such as VLDL, LDL and HDL to transport lipids in the blood and central nervous system (CNS). In the CNS, ApoE is mainly involved in nerve growth and regeneration. It binds amyloid-β peptides and plays a role in their degradation. Accumulation and deposition of amyloid-β peptides in CNS is known to be a molecular cause of Alzheimer's disease.

Three alleles of the APOE gene, ε2, ε3, and ε4, give rise to the major ApoE isoforms, which differ by 2 amino acids: ApoE2 contains Cys112/Cys158, ApoE3 Cys112/Arg158, and ApoE4 Arg112/Arg158. There are 3 homozygous phenotypes (E2/2, E3/3, E4/4) and 3 heterozygous (E2/3, E3/4, E2/4).

The EURORealTime APOE test provides qualitative molecular testing of the e2/e2, e2/e3, e3/e3, e2/e4, e3/e4 and e4/e4 genotypes in the APOE gene by real-time PCR. The product can be used as an aid in the proactive evaluation of risk factors for the anti-amyloid-beta (Aβ) antibody treatment in patients with Alzheimer's disease.

Friedreich Ataxia (FRDA) diagnostic testing

This assay determines the presence or absence of homozygous GAA triplet repeat expansion in intron 1 of FXN gene.

The DNA surrounding the GAA repeat in the FXN gene is amplified by long-range PCR followed by e-gel electrophoresis. All normal sized alleles and a vast majority of the expanded alleles will be detected in this analysis.

Premade library sequencing services

Our premade library sequencing service is designed to provide researchers with flexible and affordable access to high-quality flow cells for their sequencing projects without the need for significant upfront investment in equipment.

Whether you're working on genomic, or other sequencing applications, our premade library sequencing service ensures you have cutting edge technology at your disposal, backed by our expert technical support to help you achieve reliable results.

Contact Revvity Omics for more information